News

Advisers to the FDA will debate if the virus has mutated enough since last winter to require a tweak to the formula.
Novavax (NasdaqGS:NVAX) recently reported a significant financial turnaround for Q1 2025, demonstrating substantial revenue growth and net income improvements. The amending of its collaboration ...
The FDA’s decision to adopt a risk-based framework for the COVID-19 vaccine aligns with the expected recommendations from the Advisory Committee on Immunization Practices, an ad ...
WASHINGTON — Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by ...